Patents by Inventor Kellie Schaefer

Kellie Schaefer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250137011
    Abstract: Provided are methods for treating an ocular neovascular disease in an individual, comprising administering a unit dose of recombinant adeno-associated virus (rAAV) particles to an eye of the individual, wherein the rAAV particles comprise: a) a nucleic acid encoding a polypeptide comprising an amino acid sequence with at least about 95% identity to the amino acid sequence of SEQ ID NO: 35 and flanked by AAV2 inverted terminal repeats (ITRs), and b) an AAV2 capsid protein comprising an amino acid sequence LGETTRP (SEQ ID NO: 14) inserted between positions 587 and 588 of the capsid protein, wherein the amino acid residue numbering corresponds to an AAV2 VP1 capsid protein.
    Type: Application
    Filed: February 1, 2023
    Publication date: May 1, 2025
    Applicant: Adverum Biotechnologies, Inc.
    Inventors: Kelly Hanna, Kellie Schaefer-Swale, Brigit Riley, Ruslan Grishanin, Adam Turpcu, Richard Beckman
  • Patent number: 11981943
    Abstract: The present disclosure provides CAPN5 substrates and CAPN5 inhibitors, nucleic acids encoding CAPN5 substrates or CAPN5 inhibitors, methods to deliver CAPN5 substrate or CAPN5 inhibitor agents to the eye, and methods of identifying inhibitors of CAPN5.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: May 14, 2024
    Assignee: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: Vinit B. Mahajan, Alexander G. Bassuk, Diana F. Colgan, Gabriel Velez, Kellie Schaefer, Marcus Toral, Shu Wu, Lokesh Gakhar
  • Publication number: 20190284544
    Abstract: The present disclosure provides CAPN5 substrates and CAPN5 inhibitors, nucleic acids encoding CAPN5 substrates or CAPN5 inhibitors, methods to deliver CAPN5 substrate or CAPN5 inhibitor agents to the eye, and methods of identifying inhibitors of CAPN5.
    Type: Application
    Filed: October 2, 2017
    Publication date: September 19, 2019
    Applicant: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: Vinit B. Mahajan, Alexander G. Bassuk, Diana F. Colgan, Gabriel Velez, Kellie Schaefer, Marcus Toral, Shu Wu, Lokesh Gakhar
  • Patent number: 7620055
    Abstract: A method of using DOCSIS 1.1 features to allow the addition of ISPs and QOS levels to a single cable modem without having to modify the CMTS is described in the various figures. Instead of using the SID of a data packet to determine the VPN tag of a data packet (DOCSIS 1.0), a service flow is used to identify the appropriate tag. This is done using the DOCSIS 1.1 configuration file. By doing so, the need for creating additional sub-interfaces in the cable modem interface does not arise. Instead, the configuration is modified at the provisioning server, i.e., the DHCP/TFTP server.
    Type: Grant
    Filed: July 10, 2006
    Date of Patent: November 17, 2009
    Assignee: Cisco Technology, Inc.
    Inventors: Kartik Chandran, Chrisanto Leano, Sunil Khaunte, Jerry D. Goodrich, Kelly Schaefer
  • Patent number: 7092397
    Abstract: A method of using DOCSIS 1.1 features to allow the addition of ISPs and QOS levels to a single cable modem without having to modify the CMTS is described in the various figures. Instead of using the SID of a data packet to determine the VPN tag of a data packet (DOCSIS 1.0), a service flow is used to identify the appropriate tag. This is done using the DOCSIS 1.1 configuration file. By doing so, the need for creating additional sub-interfaces in the cable modem interface does not arise. Instead, the configuration is modified at the provisioning server, i.e., the DHCP/TFTP server.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: August 15, 2006
    Assignee: Cisco Technology, Inc.
    Inventors: Kartik Chandran, Chrisanto Leano, Sunil Khaunte, Jerry D. Goodrich, Kelly Schaefer